Search Tag: Asklepios BioPharmaceutical
2023 10 Mar
Asklepios BioPharmaceutical, Inc., a wholly owned and independently operated subsidiary of Bayer AG announced that Gustavo Pesquin will become the company’s next Chief Executive Officer (CEO) as of March 11, 2023. Pesquin joins AskBio from Amneal Pharmaceuticals, Inc., where he served as Chief Commercial Officer. Sheila Mikhail, Co-Founder and...Read more
2022 11 Aug
Doug Schantz joins as Senior Vice President of Clinical Operations and Phil McNamara to serve as Vice President of Communications Asklepios BioPharmaceutical , Inc. (AskBio), an independently operated subsidiary of Bayer AG, is adding two industry veterans to advance clinical operations and lead corporate communications. Doug Schantz will serve...Read more